Medication Safety and Quality Unit


To support the safe and quality use of medicines by identifying and addressing emerging medication safety risks.


The CEC Medication Safety and Quality unit oversees four programs, Continuity of Medication Management, High-Risk Medicines, Medication Safety Self Assessment and VTE Prevention.  

The Continuity of Medication Management program provides tools and resources to support medication reconciliation; the process of ensuring that patients receive all intended medicines and that accurate, current and comprehensive medicine information follows them at all transfers of care.

The High-Risk Medicines program heightens awareness of the harm that can be caused and assists in improvements to the management of high-risk medicines in hospitals in NSW.

The Medication Safety Self Assessment facilitates evaluation of systems and processes related to medicines use and highlights opportunities for improvement.

The VTE Prevention program assists health care facilities and clinical teams to implement robust processes for the prevention of hospital-associated venous thromboembolism. 


Continuity of Medication Management, High-Risk Medicines, Medication Safety Self Assessment and VTE Prevention are CEC Medication Safety and Quality programs that assist health care teams to work together and improve their local medicines-use systems.



  • NSW Therapeutic Advisory Group
  • Australian Commission on Safety and Quality in Healthcare
  • eHealth NSW
  • HETI
  • NPS MedicineWise
  • Agency for Clinical Innovation
  • Local Health Districts 

Key Dates

Pilot Sites

Western NSW Local Health DistrictOrange Health Service

Continuity of Medication Management

Dubbo Base Hospital

Continuity of Medication Management

Western Sydney Local Health DistrictBlacktown Mount Druitt Hospital (Blacktown Campus)

Continuity of Medication Management

Implementation Sites


Related Initiatives

Further Details


Project Officer, Medication Safety and Quality
02 9269 5500

Page Top | Added: 8 December 2014 | Last modified: 9 November 2015

Project Officer, Medication Safety and Quality

02 9269 5500